Gilbert Chandler, MD
Interventional Pain Medicine · Tallahassee, FLNPI 1003807272
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (40.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by CGG Medical Inc at 41.4% of the total. Reporting peaked in 2022 at $2,654 and has fallen 88.2% since, to $313 in 2025.
Across 49 payments — averaging $120.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- CGG Medical Inc$2K
- Relievant Medsystems, Inc.$2K
- Boston Scientific$673
- Nevro Corp.$240
- Medtronic$139
- Bioventus LLC$120
- plus $335 from 8 others
What the payments were for
- Travel & lodging$1,19020%
- Food & beverage$2,29739%
- Education$2,40041%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| CGG Medical Inc | 2 | $2,436 |
| Relievant Medsystems, Inc. | 11 | $1,943 |
| Boston Scientific | 11 | $673 |
| Nevro Corp. | 7 | $240 |
| Medtronic(2 entities) | 5 | $139 |
| Bioventus LLC | 1 | $120 |
| Si-bone, Inc. | 2 | $101 |
| Vertiflex, Inc. | 4 | $81 |
| Avanos Medical | 1 | $44 |
| AbbVie | 1 | $29 |
| Stryker | 1 | $26 |
| SPR Therapeutics, Inc | 1 | $23 |
| Abbott | 1 | $20 |
| Pfizer | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,887 in reported general payments places this provider in the 55th percentile of 278 interventional pain medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 2,845 | $75,404 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 1,932 | $63,525 |
| Xtampza ErOxycodone Myristate | 77 | $34,968 |
| Pregabalin | 885 | $31,010 |
| Buprenorphine | 109 | $24,931 |
| Nucynta ErTapentadol Hcl | 17 | $17,200 |
| Gabapentin | 937 | $16,835 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 97 | $14,592 |
| Tramadol Hcl | 1,249 | $12,728 |
| SuboxoneBuprenorphine Hcl/Naloxone Hcl | 24 | $11,660 |
| Buprenorphine Hcl | 109 | $6,634 |
| OxycontinOxycodone Hcl | 12 | $5,067 |
| Tramadol Hcl ErTramadol Hcl | 80 | $4,806 |
| Fentanyl | 20 | $4,675 |
| Oxycodone Hcl | 224 | $4,380 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Tallahassee
- Louis RasoJupiter$1.3M
- Ajay AntonyGainesville$1.1M
- Michael EspositoVero Beach$777K
- Nomen AzeemRiverview$650K
- Stanley GolovacMerritt Island$367K
- Sunil PanchalLutz$363K
- Robert BallPort Charlotte$246K
- Justin MannJacksonville$243K
- Giuseppe PaeseBoca Raton$180K
- Miguel de la GarzaNew Port Richey$138K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.